The Arab Company for Drug Industries and Medical Appliances (ACDIMA) has surpassed an investment milestone of 6.6 billion Egyptian pounds in the Egyptian market, according to the company’s chairman.
In the first quarter of 2023, ACDIMA recorded impressive total sales of approximately four billion pounds. This achievement underscores the company’s robust presence and success in the pharmaceutical industry, reflecting its commitment to meeting healthcare needs and contributing to the economy of Egypt.
Olfat Ghorab made her remarks during the second day not the Africa Health ExCon 2023, adding that the company aims at expanding its exports to new markets, with plans to inject more investment during the upcoming period in Egypt.
the company is currently working on several new projects. These include a project for the production of raw
The company is currently working on several new projects, include a project for the production of raw materials at a total cost of $150 million and another one for the pharmaceutical glass products at 800 million pounds, Ghorab added.
ACDIMA is implementing a project for the manufacturing of biological and bio-similar products at a cost of 2.2 billion pounds, Ghorab said, concluding that the event serves as an important promotional platform for healthcare, and pharmaceutical sectors, both locally and globally.
Ghorab further stated that President Abdel Fattah al-Sisi’s inauguration of the second edition of the conference will emphasize the magnitude of Egypt’s attentiveness toward the healthcare sector and the localization of the pharmaceutical industry in the market.
